Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Brain Oxygenation in Extremely Preterm Infants-II

NCT05171881 is registered in ClinicalTrials.gov with Valerie Chock, M.D., M.S. Epi as lead sponsor.

NCT NCT05171881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05171881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Brain Oxygenation in Extremely Preterm Infants-II
Lead sponsor
Valerie Chock, M.D., M.S. Epi
Phase
Phase 2
Overall status
Unknown status
Start date
April 7, 2022
Completion date
April 30, 2025
Enrollment
100 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral hypoxia